Ultragenyx to Present at Baird 2016 Global Healthcare Conference
September 01 2016 - 8:30AM
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical
company focused on the development of novel products for rare and
ultra-rare diseases, today announced that Shalini Sharp, the
company’s Chief Financial Officer, will be presenting at the Baird
2016 Global Healthcare Conference on Thursday, September 8 at 10:15
am ET in New York, NY.
The live and archived webcast of the company presentation will
be accessible from the company’s website at
http://ir.ultragenyx.com/events.cfm. The replay of the webcast will
be available for 90 days.
About Ultragenyx
Ultragenyx is a clinical-stage biopharmaceutical company
committed to bringing to market novel products for the treatment of
rare and ultra-rare diseases, with a focus on serious, debilitating
genetic diseases. Founded in 2010, the company has rapidly built a
diverse portfolio of product candidates with the potential to
address diseases for which the unmet medical need is high, the
biology for treatment is clear, and for which there are no approved
therapies.
The company is led by a management team experienced in the
development and commercialization of rare disease therapeutics.
Ultragenyx’s strategy is predicated upon time and cost-efficient
drug development, with the goal of delivering safe and effective
therapies to patients with the utmost urgency.
For more information on Ultragenyx, please visit the company’s
website at www.ultragenyx.com.
Contact Ultragenyx Pharmaceutical Inc.
Investors & Media
Ryan Martins
844-758-7273
Ultragenyx Pharmaceutical (NASDAQ:RARE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ultragenyx Pharmaceutical (NASDAQ:RARE)
Historical Stock Chart
From Sep 2023 to Sep 2024